“Medical cannabis laws are associated with significant reductions in opioid prescribing in the Medicare Part D population. This finding was particularly strong in states that permit dispensaries, and for reductions in hydrocodone and morphine prescriptions.”
Related Posts
Cannabinoids as novel anti-inflammatory drugs (2009)
- WOCredentials
- June 16, 2016
- 0
“It is becoming increasingly clear that cannabinoid receptors and their endogenous ligands play a crucial role in the regulation of the immune system. Exogenous cannabinoids have been shown to suppress […]
One striking chart shows why pharma companies are fighting legal marijuana
- WOCredentials
- August 15, 2016
- 0
“Our findings and existing clinical literature imply that patients respond to medical marijuana legislation as if there are clinical benefits to the drug, which adds to the growing body of […]
Cannabis induces a clinical response in patients with Crohn’s disease: a prospective placebo-controlled study (2013)
- WOCredentials
- September 19, 2016
- 0
“a short course (8 weeks) of THC-rich cannabis produced significant clinical, steroid-free benefits to 10 of 11 patients with active Crohn’s disease, compared with placebo, without side effects.” Naftali, T., […]